These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7107978)

  • 21. Effects of hemodialysis on theophylline kinetics.
    Anderson JR; Poklis A; McQueen RC; Purtell JN; Slavin RG
    J Clin Pharmacol; 1983 Oct; 23(10):428-32. PubMed ID: 6643695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefamandole kinetics in uremic patients undergoing hemodialysis.
    Gambertoglio JG; Aziz NS; Lin ET; Grausz H; Naughton JL; Benet LZ
    Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The disposition of primidone in elderly patients.
    Martines C; Gatti G; Sasso E; Calzetti S; Perucca E
    Br J Clin Pharmacol; 1990 Oct; 30(4):607-11. PubMed ID: 2291873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of primidone and its active metabolites in the dog.
    Frey HH; Göbel W; Löscher W
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):14-30. PubMed ID: 543743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.
    Blum RA; Olson SC; Kohli RK; Horvath AM; Sedman AJ; Posvar EL
    J Clin Pharmacol; 1990 Oct; 30(10):938-42. PubMed ID: 2229454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and hemodialyzability of cefazolin in uremic patients.
    Craig CP; Rifkin SI
    Clin Pharmacol Ther; 1976 Jun; 19(6):825-9. PubMed ID: 773590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ritanserin in patients undergoing hemodialysis.
    Zazgornik J; Kuska J; Kokot F; Koch S; Van Peer A; Huang ML; Heykants J
    J Clin Pharmacol; 1991 Jul; 31(7):657-61. PubMed ID: 1910052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of ceftriaxone in hemodialysis].
    Laville M; Mercatello A; Freney J; Pozet N; Meugnier H; Labeeuw M; Fleurette J; Zech P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):719-23. PubMed ID: 3309803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
    Kaplan SL; Berry PL; Mason EO; Kramer WG
    Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the pharmacokinetics, pharmacodynamics, and dialyzability of verapamil in chronic hemodialysis patients.
    Hanyok JJ; Chow MS; Kluger J; Izard MW
    J Clin Pharmacol; 1988 Sep; 28(9):831-6. PubMed ID: 3230150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of felodipine in chronic hemodialysis patients.
    Buur T; Larsson R; Regårdh CG; Aberg J
    J Clin Pharmacol; 1991 Aug; 31(8):709-13. PubMed ID: 1880229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients.
    Garg DC; Baltodano N; Perez GO; Oster JR; Jallad NS; Weidler DJ
    Pharmacology; 1985; 31(4):189-93. PubMed ID: 4059323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronidazole kinetics in dialysis patients.
    Kreeft JH; Ogilvie RI; Dufresne LR
    Surgery; 1983 Jan; 93(1 Pt 2):149-53. PubMed ID: 6849199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-dose kinetics of primidone in acute viral hepatitis.
    Pisani F; Perucca E; Primerano G; D'Agostino AA; Petrelli RM; Fazio A; Oteri G; Di Perri R
    Eur J Clin Pharmacol; 1984; 27(4):465-9. PubMed ID: 6519155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.
    Halpren BA; Axline SG; Coplon NS; Brown DM
    J Infect Dis; 1976 Jun; 133(6):627-36. PubMed ID: 932490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primidone kinetics: effects of concurrent drugs and duration of therapy.
    Cloyd JC; Miller KW; Leppik IE
    Clin Pharmacol Ther; 1981 Mar; 29(3):402-7. PubMed ID: 7471611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of gabapentin in anuric subjects on hemodialysis.
    Wong MO; Eldon MA; Keane WF; Türck D; Bockbrader HN; Underwood BA; Sedman AJ; Halstenson CE
    J Clin Pharmacol; 1995 Jun; 35(6):622-6. PubMed ID: 7665723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.